Active-ingredient Dossier
Riluzole
Active-ingredient Dossier for Riluzole (amyotrophic lateral sclerosis agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: RILUZOLE
- Brand: TEGLUTIK
- Brand: RILUKEM
- Brand: RILUTEK
- Brand: APO-RILUZOLE
- Brand: APOTEX-RILUZOLE
- Therapeutic area: Neurology
What is
Riluzole Riluzole is an amyotrophic lateral sclerosis agent.
Australian brands containing
Riluzole — RILUZOLE — TEGLUTIK — RILUTEK — RILUKEM — APO-RILUZOLE — APOTEX-RILUZOLE
Therapeutic areas
Riluzole is registered in neurology, with 6 brands containing the ingredient on the ARTG.
Sponsor landscape
Riluzole is marketed by five sponsors: Arrotex Pharmaceuticals, Pharmacor, Sanofi-Aventis, Sandoz, and Asteri Pharma.
PBS and regulatory activity
Two brands containing riluzole have PBS-listed items, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome on record is from 1 November 2018.